Effects of Berberine Hydrochloride and Bifidobacterium in Prediabetes Prevention and Treatment an Open-label, Multicenter-Randomized, Prospective-Controlled Study

Trial Profile

Effects of Berberine Hydrochloride and Bifidobacterium in Prediabetes Prevention and Treatment an Open-label, Multicenter-Randomized, Prospective-Controlled Study

Not yet recruiting
Phase of Trial: Phase II/III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Berberine (Primary) ; Bifidobacteria (Primary)
  • Indications Prediabetic-state
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top